Safety of newly approved drugs - Implications for prescribing

被引：121

作者：

Temple, RJ ^{[1
]}

Himmel, MH ^{[1
]}

机构：

[1] US FDA, Ctr Drug Evaluat & Res Policy, Rockville, MD 20857 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 17期

关键词：

D O I：

10.1001/jama.287.17.2273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2273 / 2275

页数：3

共 50 条

[1] Improving the safety of newly approved drugs
[J]. Reactions Weekly, 2002, 901 (1) : 3 - 3
[2] Safety of newly approved drugs questioned
不详
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (12) : 1147 - 1147
[3] A new look at safety for newly approved drugs
[J]. Reactions Weekly, 2008, 1199 (1) : 2 - 2
[4] ISMP focusses on safety of newly approved drugs in US
[J]. Reactions Weekly, 2019, 1734 (1) : 4 - 4
[5] Newly approved drugs for children
Abbott, MB
Levin, RH
[J]. PEDIATRICS IN REVIEW, 2003, 24 (07) : 240 - 243
[6] Efficacy, safety, tolerability and price of newly approved drugs in solid tumors
Barnes, Tristan A.
Amir, Eitan
Templeton, Arnoud J.
Gomez-Garcia, Susana
Navarro, Beatriz
Seruga, Bostjan
Ocana, Alberto
[J]. CANCER TREATMENT REVIEWS, 2017, 56 : 1 - 7
[7] Efficacy, safety, tolerability and price of newly approved drugs in solid tumors.
Barnes, Tristan Alexandra
Amir, Eitan
Templeton, Arnoud J.
Garcia, Susana Gomez
Navarro, Beatriz
Seruga, Bostjan
Ocana, Alberto
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8] Pharmacoepidemiology in Safety Evaluations of Newly Approved Medications
Elane M. Gutterman
[J]. Drug information journal : DIJ / Drug Information Association, 2004, 38 (1): : 61 - 67
[9] Pharmacoepidemiology in safety evaluations of newly approved medications
Gutterman, EM
[J]. DRUG INFORMATION JOURNAL, 2004, 38 (01): : 61 - 67
[10] Publication trends associated with newly approved orphan drugs
Woods, Catherine
Kitchens, Elizabeth A.
Zoog, Holly
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 : 25 - 25

← 1 2 3 4 5 →